Neuberger Berman Group LLC Royalty Pharma PLC Transaction History

Neuberger Berman Group LLC

$118 Billion
Q2 2024

A detailed history of Neuberger Berman Group LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Neuberger Berman Group LLC holds 7,773 shares of RPRX stock, worth $215,700. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,773

Previous 21,336 63.57%

Holding current value

$215,700

Previous $647,000 68.47%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$26.26 - $29.9 $356,164 - $405,533	-13,563 Reduced 63.57%	7,773 $204,000
Q1 2024 May 13, 2024	BUY	$27.46 - $31.33 $585,886 - $668,456	21,336 New	21,336 $647,000
Q4 2023 Feb 09, 2024	SELL	$26.21 - $29.22 $13.4 Million - $15 Million	-511,692 Reduced 96.39%	19,142 $537,000
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $49,395 - $59,025	1,881 Added 0.36%	530,834 $14.4 Million
Q2 2023 Aug 11, 2023	SELL	$29.6 - $36.56 $207,614 - $256,431	-7,014 Reduced 1.31%	528,953 $16.3 Million
Q1 2023 May 12, 2023	SELL	$32.77 - $39.4 $245,578 - $295,263	-7,494 Reduced 1.38%	535,967 $19.3 Million
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $169,136 - $190,164	4,318 Added 0.8%	543,461 $21.5 Million
Q3 2022 Nov 15, 2022	BUY	$39.88 - $44.65 $4,346 - $4,866	109 Added 0.02%	539,143 $21.7 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $5.79 Million - $6.82 Million	154,190 Added 40.07%	539,034 $22.7 Million
Q1 2022 May 13, 2022	BUY	$37.46 - $42.44 $14 Million - $15.9 Million	374,844 Added 3748.44%	384,844 $15 Million
Q2 2020 Aug 13, 2020	BUY	$44.5 - $52.11 $445,000 - $521,100	10,000 New	10,000 $486,000

Others Institutions Holding RPRX

# of Institutions

396

Shares Held

291M

Call Options Held

305K

Put Options Held

138K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $12.1B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Royalty Pharma PLC Transaction History